Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E K Gordon

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 1, 1971
3 -Methoxy- 4 -hydroxyphenylethylene glycol in human cerebrospinal fluidE K Gordon, J Oliver
The Nurse Practitioner|November 1, 1994
Guidelines for forming an advanced practice nursing coalition: the Ohio experienceE K Gordon, J R Golden
Life Sciences|May 15, 1975
The effect of probenecid on catecholamine metabolites in human cerebrospinal fluid analyzed by mass fragmentographyE K Gordon, J Oliver, I J Kopin
Annals of Clinical and Laboratory Science|January 1, 1976
Biochemical aids in the diagnosis of Parkinson's diseaseT N Chase, N Eng, E K Gordon
Topics in Emergency Medicine|March 12, 1982
Immunoprophylaxis in the emergency departmentE K Gordon, J C Brill, J M Geiderman
Science (New York, N.Y.)|July 8, 1977
Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnoverP Lerner, P Nosé, E K Gordon, et al.
Annals of Emergency Medicine|April 1, 1981
Immunoprophylaxis of viral hepatitisE K Gordon, J M Geiderman, J C Brill
The New England Journal of Medicine|April 23, 1970
Depressed monoamine catabolite levels in cerebrospinal fluid of patients with parkinsonism dementia of GuamJ A Brody, T N Chase, E K Gordon
Neuropharmacology|May 1, 1970
Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disordersT N Chase, J A Schnur, E K Gordon
Journal of Neurochemistry|September 1, 1973
Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluidT N Chase, E K Gordon, L K Ng
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 1, 1971
3 -Methoxy- 4 -hydroxyphenylethylene glycol in human cerebrospinal fluidE K Gordon, J Oliver
The Nurse Practitioner|November 1, 1994
Guidelines for forming an advanced practice nursing coalition: the Ohio experienceE K Gordon, J R Golden
Life Sciences|May 15, 1975
The effect of probenecid on catecholamine metabolites in human cerebrospinal fluid analyzed by mass fragmentographyE K Gordon, J Oliver, I J Kopin
Annals of Clinical and Laboratory Science|January 1, 1976
Biochemical aids in the diagnosis of Parkinson's diseaseT N Chase, N Eng, E K Gordon
Topics in Emergency Medicine|March 12, 1982
Immunoprophylaxis in the emergency departmentE K Gordon, J C Brill, J M Geiderman
Science (New York, N.Y.)|July 8, 1977
Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnoverP Lerner, P Nosé, E K Gordon, et al.
Annals of Emergency Medicine|April 1, 1981
Immunoprophylaxis of viral hepatitisE K Gordon, J M Geiderman, J C Brill
The New England Journal of Medicine|April 23, 1970
Depressed monoamine catabolite levels in cerebrospinal fluid of patients with parkinsonism dementia of GuamJ A Brody, T N Chase, E K Gordon
Neuropharmacology|May 1, 1970
Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disordersT N Chase, J A Schnur, E K Gordon
Journal of Neurochemistry|September 1, 1973
Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluidT N Chase, E K Gordon, L K Ng
Pageof 4